Title : Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential.

Pub. Date : 2008

PMID : 19337535






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sitagliptin and vildagliptin represent a new class of anti-diabetic agents that enhance the action of incretin hormones through inhibition of dipeptidyl peptidase-4 (DPP-4), the enzyme that normally inactivates incretin hormones. Vildagliptin dipeptidyl peptidase 4 Homo sapiens
2 Sitagliptin and vildagliptin represent a new class of anti-diabetic agents that enhance the action of incretin hormones through inhibition of dipeptidyl peptidase-4 (DPP-4), the enzyme that normally inactivates incretin hormones. Vildagliptin dipeptidyl peptidase 4 Homo sapiens